Parathyroid Hormone 1-34(Teriparatide) Treatment in Pelvic Insufficiency Fractures: A Report of Two Cases
Journal of Bone Metabolism
;
: 147-151, 2012.
Article
in English
| WPRIM
| ID: wpr-174455
ABSTRACT
As a result of aging population, the incidence of pelvic insufficiency fracture has been increasing. Pain-related immobility caused by pelvic insufficiency fractures may result in a serious dependency and high mortality with preexisting comorbidities. We present two cases of pelvic insufficiency fracture in elderly patients which had good clinical outcome by parathyroid hormone 1-34(teriparatide) treatment as well as a literature review.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteoporosis
/
Parathyroid Hormone
/
Pelvis
/
Aging
/
Comorbidity
/
Fractures, Stress
/
Incidence
/
Dependency, Psychological
Type of study:
Incidence study
/
Prognostic study
Limits:
Aged
/
Humans
Language:
English
Journal:
Journal of Bone Metabolism
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS